This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Acne Vulgaris
and you are
over 9
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The objectives of this study are to assess the safety and efficacy of Olumacostat Glasaretil Gel compared to vehicle in patients with acne vulgaris

Provided treatments

  • Drug: Olumacostat Glasaretil Gel, 5.0%
  • Other: Olumacostat Glasaretil Gel, Vehicle

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028363. The sponsor of the trial is Dermira, Inc. and it is looking for 759 volunteers for the current phase.
Official trial title:
A Randomized, Double-blind, Vehicle Controlled, Efficacy and Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris